Skip to main content
. Author manuscript; available in PMC: 2023 Jun 8.
Published in final edited form as: Neurocrit Care. 2022 Dec 28;38(3):771–780. doi: 10.1007/s12028-022-01652-7

Fig. 2.

Fig. 2

Plasma and cerebrospinal fluid (CSF) levels of leucine-rich alpha-2-glycoprotein 1 (LRG1) in study participants with subarachnoid hemorrhage (SAH) and controls. Plasma LRG1 levels are significantly (p < 0.001) higher in study participants with SAH compared with cardiac controls. CSF levels (log-normalized) of LRG1 levels are not significantly higher compared with those in TGN controls